A Retrospective Study to Evaluate the Early Real-world Evidence of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) in India
Clinical trial NCT05834075 · COMPLETED
Trial details
- NCT number
- NCT05834075
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-05
- Primary completion
- 2022-04-22
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.